Key Drivers
- Cash Conversion
- Liquidity Stress
- Thin Margins
AIAI Summary
CAH should now be viewed less as a cheap defensive distributor and more as a cash-generative, specialty-led compounder whose upside depends on continued execution in specialty pharma and disciplined capital returns, because thin margins, weak liquidity/negative equity, and the recent re-rating leave little room for setbacks.
Price Chart
Financial Metrics
Deep Analysis
Research tool. Not personalized advice.
Fundamental Analysis
Key Financial Insights:
- •Cash Conversion
- •Liquidity Stress
- •Thin Margins
Cardinal Health generates strong cash flow and solid revenue scale, but thin margins, weak liquidity, negative equity, and elevated earnings multiples make it a constrained, not clearly cheap, investment.
Price Behavior
Key Price Behavior Insights:
- •Higher lows
- •Held support
- •Extended rally
CAH remains in a strong last month uptrend with higher lows and firm momentum, but the stock is extended and now needs to hold $235-$237 support to avoid a short-term pullback.
Fast rally from $195.42 to $238.94 left shares extended and prone to a pullback
Sentiment & News
Key News Insights:
- •Growth acceleration
- •52-week high
- •Premium valuation
Cardinal Health (CAH) is being viewed favorably across value, growth, and momentum lenses as strong revenue/EPS growth, a 52-week high, and bullish Buy-rated coverage outweigh valuation concerns.
The news flow is constructive for CAH, supporting upside momentum as investors focus on improving profitability and cash flow
Similar Companies in Healthcare
Other companies in the same sector with AI ratings